Endonasal endoscopic approach for sellar metastatic pathologies: a national observation

dc.authorscopusidAli Erdem Yıldırım / 37021916800
dc.authorscopusidYahya Efe Güner / 57378188800
dc.authorwosidYahya Efe Güner / DVX-1803-2022
dc.contributor.authorGüner, Yahya Efe
dc.contributor.authorKahıloğulları, Gökmen
dc.contributor.authorBayatlı, Eyüp
dc.contributor.authorTanrıverdi, Osman
dc.contributor.authorTarkan, Özgür
dc.contributor.authorIşıkay, İlkay
dc.contributor.authorCivriz Bozdağ, Sinem
dc.contributor.authorCeylan, Savaş
dc.contributor.authorYıldırım, Ali Erdem
dc.date.accessioned2022-05-23T08:32:01Z
dc.date.available2022-05-23T08:32:01Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Hastaneen_US
dc.description.abstractPURPOSE Sellar metastases are rare lesions. Recent improvements in diagnosis and treatment strategies have prolonged survival but increased the probability of metastatic tumors. Evaluation with clinical symptomatology and meticulous laboratory examination is crucial. We present our multicenter national study on sellar metastases to evaluate and underline the main clinical, endocrine, and radiological considerations regarding the diagnosis and endonasal endoscopic management of such rare lesions. METHODS A medical literature-based retrospective study was planned across 13 neurosurgical centers in Turkey, where a data survey was conducted to collect information regarding sellar metastases surgically treated using the endoscopic endonasal approach, including clinical presentation, radiographic features, primary tumor origin, histopathological confirmation, time to metastasis, treatment, and patient outcomes. RESULTS Between 2010 and 2020, 54 patients (22 women [40.7%] and 32 men [59.3%]) who underwent surgery with the endonasal endoscopic approach and had pathologically proven sellar metastases (overall incidence, 0.54%) were included. Of the patients, 59.3% had no known malignancy and presented with new-onset symptoms, 79.6% reported headache, 51.9% complained of some degree of visual deficits, and 50% had cranial nerve symptoms. Tissue biopsy was performed in 7.4% of the patients, whereas gross or subtotal resection was achieved in the remaining patients. CONCLUSION To our knowledge, this is the largest series of patients surgically treated with the endonasal endoscopic approach for sellar metastases. For these patients, the treatment focus should be on management modalities for increasing quality of life instead radical treatment options with survival benefit.en_US
dc.identifier.citationKahilogullari G, Bayatli E, Geyik M, Cabuk B, Beton S, Gunaldi O, Tanrıverdi O, Cetinalp NE, Tarkan O, Yıldırım AE, Guner YE, Nehir A, Goksu E, Akyuz M, Isikay İ, Duz B, Celtikci E, Kertmen H, Köktekir E, Camlar M, Bahçecioğlu Mutlu AB, Cansız Ersoz C, Bozdag SC, Berker M, Ceylan S. Endonasal endoscopic approach for sellar metastatic pathologies: a national observation. Br J Neurosurg. 2022 May 18:1-7. doi: 10.1080/02688697.2022.2077310. Epub ahead of print. PMID: 35582922.en_US
dc.identifier.doi10.1080/02688697.2022.2077310en_US
dc.identifier.issn0268-8697en_US
dc.identifier.issue7en_US
dc.identifier.pmid35582922en_US
dc.identifier.scopus2-s2.0-85130609977en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttp://doi.org/10.1080/02688697.2022.2077310
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2706
dc.identifier.volume1en_US
dc.identifier.wosWOS:000797363700001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor and Francisen_US
dc.relation.ispartofBritish Journal of Neurosurgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEndonasalen_US
dc.subjectEndoscopicen_US
dc.subjectSellar Pathologyen_US
dc.subjectMetastasisen_US
dc.subjectNational Reporten_US
dc.titleEndonasal endoscopic approach for sellar metastatic pathologies: a national observationen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
02688697.2022.pdf
Boyut:
4.87 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: